Telmisartan Versus Ramipril After Acute Coronary Syndrome
Status:
Unknown status
Trial end date:
2008-11-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to compare the antinflammatory and endothelial progenitor cell
(EPC) mobilizing effect of Ramipril and Telmisartan in patients presenting with acute
coronary syndrome